Applied and Environmental Microbiology, September 2002, p. 4173-4181, Vol. 68, No. 9
0099-2240/02/$04.00+0 DOI: 10.1128/AEM.68.9.4173-4181.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Departments of Plant Pathology,1 Botany, North Carolina State University, Raleigh, North Carolina 27695-76162
Received 14 February 2002/ Accepted 17 June 2002
|
|
|---|
|
|
|---|
![]() View larger version (26K): [in a new window] |
FIG. 1. Structures of cercosporin, xanosporic acid, xanosporolactone, and hypericin. Spectral analysis indicated that the green degradation product produced in culture is xanosporic acid, which is converted to its more stable lactone form during acidification for extraction from the medium.
|
Several lines of evidence indicate that cercosporin plays a crucial role in the ability of Cercospora species to infect host plants. The toxin is produced by many members of the genus and can be extracted from infected tissue (18, 27, 31). Membrane damage in infected tissue is consistent with the mode of action of cercosporin (13, 22), and the requirement of light for symptom development in Cercospora diseases is well documented in several hosts (5, 6, 42). The most compelling evidence for the role of cercosporin in disease development is the finding that cercosporin-deficient mutants of Cercospora kikuchii are not pathogenic on soybean (43). These data suggest that strategies that interfere with cercosporin, such as toxin resistance or toxin degradation, may be useful for developing resistance to Cercospora diseases. Current control strategies include host resistance, cultural practices, and chemical applications, which may be used in conjunction with disease prediction models (8, 10, 36, 44, 46). With the exception of one report for rice (3), host resistance to Cercospora diseases has not been correlated with resistance to cercosporin or interference with cercosporin production or action. A long-term goal of our work is to identify the cercosporin degradation genes and to transfer them into plants in order to develop transgenic resistance to Cercospora diseases.
Microorganisms are attractive sources of genes that code for proteins that modify complex organic molecules. In 1993 Robeson et al. filed a patent describing a method to identify bacteria with the capacity to degrade cercosporin (37). Bacteria identified by this method (Bacillus thuringiensis, Pseudomonas fluorescens biovar V, Mycobacterium sp., and Bacillus subtilis) were not resistant to cercosporin in the light, yet they were able to degrade it in the dark. Degradation was determined by the ability of the bacterial isolates to generate a cleared zone in cercosporin-containing medium. To further demonstrate degradation, 14C-labeled cercosporin was incorporated into solid culture medium and incubated with cercosporin-degrading bacteria. The amount of radioactive carbon in cleared zones was significantly less than the amount observed in medium retaining the red color of cercosporin.
This study was performed to document degradation of the complex polyketide toxin cercosporin with the expectation that the information obtained may lead to future novel control strategies for cercosporin-producing pathogens. The objectives of this study were to identify the diversity of bacteria with the ability to degrade cercosporin, to investigate the kinetics of toxin degradation, and to isolate the product of cercosporin degradation in an attempt to elucidate how the degrading reactions proceed. Here we present the results of our screening analysis and of our characterization of the degrading phenotype and an initial description of the nontoxic cercosporin breakdown product not observed by Robeson et al.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Degradation of cercosporin by bacterial isolatesa
|
Screen for cercosporin-degrading bacteria.
Bacterial isolates were grown on solid LB medium for 48 h or until colonies were visible. Each isolate was then inoculated onto NACE medium (nutrient agar [Difco] containing 50 µM cercosporin) and incubated in the dark for 12 days at 28°C. The solidified medium was red due to the addition of cercosporin, and toxin degradation was indicated by a clear zone surrounding a bacterial colony (Fig. 2). The concentration of cercosporin remaining in the medium was determined by removing the medium directly below a colony with a no. 3 cork borer and extracting the crushed medium for 12 h in 250 µl of acetone at room temperature in the dark. Remaining agar particles were removed by centrifugation, and the supernatant was assayed for cercosporin. Concentrations of cercosporin were calculated spectrophotometrically from the absorbance measured at cercosporin's absorbance maximum at 473 nm by using 26,600 as the molar extinction coefficient (32).
![]() View larger version (174K): [in a new window] |
FIG. 2. Plate assay for cercosporin degradation. Bacteria were inoculated onto plates containing NACE medium and incubated in the dark for 12 days at 28°C. The degrading isolates (all isolates except the top center isolate) retained the normal colony color and showed distinct clearing of the cercosporin in the medium surrounding the colonies. The nondegrading isolate (top center isolate) was purple and did not produce the distinct halo produced by the degrading isolates.
|
Time course of breakdown product accumulation.
Log-phase cultures of isolate XCZ-3 in LB medium containing 50 µM cercosporin were incubated in the dark at 28°C for 108 h. A 5-ml sample of culture medium was removed every 12 h. Cercosporin and the green breakdown product were isolated from each sample as follows. The sample was briefly shaken in 2 ml of chloroform and then centrifuged at 9,715 x g for 2 min to separate the aqueous and organic phases. The organic phase containing any nondegraded cercosporin was removed. The green breakdown product was removed from the remaining aqueous phase, following adjustment of the pH of the sample to 2.0 with 1 N HCl, by an additional chloroform extraction. The chloroform was evaporated from the sample, and the residue was resuspended in acetone. The absorbance for cercosporin and the absorbance for the breakdown product were measured at 472 and 451 nm, respectively (the absorbance maxima of the two molecules).
Isolation of the green product.
Liquid medium cultures of isolate XCZ-3 containing 50 µM cercosporin were incubated in the dark at 28°C for 48 to 60 h, at which time the pH of the medium was 8.4 and the green degradation product (subsequently identified as xanosporic acid [Fig. 1]) was present as a water-soluble anion. Residual cercosporin was removed by adding 0.25 volume of chloroform, shaking, and allowing the phases to separate. The organic layer was removed, and the aqueous layer was acidified to pH 2 with 1 N HCl, which was subsequently shown to cause lactonization of xanosporic acid to form xanosporolactone (Fig. 1). A second chloroform extraction was performed, and the organic phase containing the green xanosporolactone product was collected and centrifuged at 9,715 x g to separate the cellular debris and the remaining aqueous phase. The chloroform was evaporated, and the resulting green solid was dissolved in acetone and stored in the dark at -20°C.
Further purification of the green xanosporolactone product was achieved by using thin-layer chromatography (TLC). The partially purified extract was loaded onto 500-µm Whatman silica gel plates and was resolved by using a solvent system consisting of ethyl acetate, hexane, methanol, and water (6:4:1.5:1). A green band at an Rf of 0.84 was scraped off each glass plate support, and the product was eluted from the silica gel matrix with ethyl acetate. After evaporation of the ethyl acetate, the residue was dissolved in 40% acetonitrile-water. Final purification was done by passing the extract over a C8 Accu-Bond solid-phase extraction resin (J & W Scientific, Folsom, Calif.). The extract was applied to the column, and the column was washed with 2 bed volumes of 40% acetonitrile-water and 4 bed volumes of hexane to elute any contaminants. The green product retained by the C8 matrix was eluted with 1 bed volume of acetone and stored at -20°C in the dark. The final purity of the green xanosporolactone product was assayed by using TLC plates containing a fluorescent indicator. No fluorescing quenching or phosphomolybdic acid-oxidizable impurities were detected. Due to the high degree of sensitivity of the green xanosporolactone product to light, extraction and purification were performed under conditions that minimized light exposure.
Toxicity assays.
Two assays were used to determine the toxicity of the green product. First, the toxicity of the unpurified xanosporic acid product was tested with a cercosporin-sensitive mutant of Cercospora nicotianae (CS-8) (26). Flasks containing malt medium (per liter: 15 g of malt extract, 3 g of peptone, 30 g of glucose) supplemented with 10 µM cercosporin were inoculated with XCZ-3 and incubated in the dark at 28°C with constant agitation. After 8 days of incubation, the bacteria were removed from the medium by centrifugation at 10,000 rpm for 10 min. Ground mycelium of C. nicotianae mutant CS-8 was then inoculated into the bacterium-free medium and grown for 7 days in the light (54 microeinsteins·m-2·s-1). The controls included cercosporin-containing medium preinoculated with XCP-76, malt medium alone (no cercosporin) preincubated with isolate XCZ-3, and malt medium alone with no preincubation. The growth of mutant CS-8 in all preparations was determined by harvesting the fungal mass by vacuum filtration, lyophilizing the fungal mass, and weighing the dried material.
The toxicity of the purified xanosporolactone product was measured by a plant infiltration assay. Eight-week-old leaf tissue of tobacco cultivar Burley-21 was treated with a solution of the chromatographically purified green product (ca. 1, 5, 10, and 50 µM) dissolved in 20% acetone. The concentrations were adjusted by using the molar extinction coefficient of reduced cercosporin (17,600), which also has a green chromophore, and were therefore approximate. Cercosporin controls were infiltrated at concentrations of 0.8 and 1.5 µM, along with a control consisting of 20% acetone alone. Each concentration of the green xanosporolactone product and controls was infiltrated at two sites per leaf on three different plants. The plants were allowed to grow in the greenhouse, and lesions were evaluated after 4 and 8 days.
Spectral analysis of the purified xanosporolactone product.
The absorbance of each sample examined in acetone was determined with a Beckman DU650 spectrophotometer. Electrospray ionization experiments were performed with a Micromass Quattro II triple quadrupole mass spectrometer equipped with an electrospray ionization source (Micromass, Inc., Manchester, United Kingdom); each sample was injected in acetonitrile-water (80:20), and the mass spectra were acquired at cone voltage settings of 30 and 60 eV. Low- and high-resolution mass spectra were measured with direct probe fast atom bombardment (FAB) by using a JOEL HX110HF spectrometer. Both electrospray ionization and FAB experiments were conducted at the Mass Spectrometry Laboratory for Biotechnology Research, Department of Chemistry, North Carolina State University.
|
|
|---|
Characterization of the degrading phenotype.
Cercosporin-degrading isolates XCZ-3 and XCP-77 were examined for the ability to use cercosporin as a sole carbon source when they were grown on a minimal salts medium amended with 30 µM cercosporin. These two isolates were unable to grow in the dark on this medium, indicating that they were not able to use cercosporin as a sole carbon source (data not shown). These data suggest that the degrading bacteria derive no carbon from the degradation of cercosporin.
The degrading isolate XCZ-3 and the nondegrading isolate XCP-76 were assayed for the ability to grow on cercosporin-containing medium in the light. These two isolates were spotted on LB medium containing 0.7, 1.0, 1.25, and 2 µM cercosporin and incubated in the presence of constant light (75 microeinsteins·m-2·s-1). XCZ-3 was able to grow on 0, 1.0, and 1.25 µM cercosporin, whereas XCP-76 was unable to grow on cercosporin at any of these concentrations. Thus, the ability to degrade cercosporin provides a small but measurable increase in cercosporin resistance.
Cercosporin-degrading isolate XCZ-3 was tested for the ability to degrade hypericin (Fig. 1), a phenanthroperylenequinone photosensitizer produced by the herb St. John's wort (Hypericum perforatum). XCZ-3 was grown in LB medium with 20 µg of hypericin per ml. After 60 h, the amount of hypericin in the culture medium was assayed spectrophotometrically. At this time, no loss of hypericin from the culture medium was detected (data not shown). Thus, XCZ-3 is not able to degrade the phenanthroperylenequinone, indicating that the degradation reaction is specific for structural constituents found in the cercosporin molecule but not in hypericin.
Time course for cercosporin degradation and accumulation of the breakdown product.
The kinetics of cercosporin degradation was determined by growing isolates XCP-76, XCP-77, and XCZ-3 in the dark in cercosporin-containing LB medium and quantifying the cercosporin concentration spectrophotometrically at 12-h intervals up to 108 h. The experiment was performed three times with comparable results; the results of one experiment are shown in Fig. 3. In the absence of light, cercosporin is stable in liquid medium, as shown by the lack of change in the cercosporin concentration in medium lacking bacteria. Nondegrading isolate XCP-76 did not cause any loss of cercosporin. The two cercosporin-degrading isolates (XCP-77 and XCZ-3) decreased the concentration of cercosporin in the medium to nondetectable levels. In all experiments, isolate XCZ-3 initiated cercosporin breakdown earlier than isolate XCP-77. Once breakdown was initiated, the rates and overall extents of degradation were similar for the two isolates.
![]() View larger version (16K): [in a new window] |
FIG. 3. Kinetics of cercosporin degradation by bacteria: concentrations of cercosporin present in cercosporin-containing medium alone (Uninoculated) or following inoculation with a nondegrading isolate (X. campestris pv. pruni XCP-76) or two degrading isolates (X. campestris pv. pruni XCP-77 and X. campestris pv. zinniae XCZ-3) at various times after inoculation. The cercosporin concentration was determined by extracting cercosporin from the medium and measuring the absorbance of the organic extract at 473 nm. The cercosporin concentrations in the uninoculated control and in the preparation inoculated with XCP-76 did not decrease over time. The kinetics of cercosporin degradation by XCP-77 and XCZ-3 were similar except for a 48-h lag in the initiation of degradation by XCP-77.
|
![]() View larger version (11K): [in a new window] |
FIG. 4. Kinetics of loss of cercosporin and accumulation of the green product in cercosporin-containing medium inoculated with the cercosporin-degrading bacterium X. campestris pv. zinniae isolate XCZ-3. Compounds were extracted and quantified as described in Materials and Methods. Following a decrease in the cercosporin concentration during the first 12 h after inoculation, the breakdown product was first detected at 24 h and the concentration increased until 60 h. After 60 h, there was a dramatic decrease in the amount of the breakdown product, suggesting that further metabolism occurred. By 132 h, all cercosporin was removed from the culture medium. This experiment was repeated once, and the two experiments yielded comparable results.
|
The TLC-purified green product was characterized further. Spectral analysis of this product identified it as xanosporolactone (Fig. 1). Subsequent analysis (T. K. Mitchell, F. Alejos-Gonzalez, H. Gracz, D. A. Danehower, M. E. Daub, and W. S. Chilton, unpublished data) indicated that the form produced by XCZ-3 in culture is xanosporic acid (Fig. 1), which upon acid extraction by the method used in this study is converted to the lactone form. The acid form is highly labile, so the product was isolated as the lactone, which we completely characterized. The absorbance and fluorescence maxima for xanosporolactone are 451 and 580 nm (dual absorbance peaks) and 557 nm, respectively, compared to maxima of 473 and 606 nm for cercosporin. Positive and negative FAB experiments revealed that the mass of xanosporolactone is 518 mass units, 16 mass units less than the mass of cercosporin (534 mass units). High-resolution mass spectra obtained by using positive FAB ionization showed that the exact mass of xanosporolactone is 518.1232 mass units and that the most probable elemental composition is C28H22O10 (518.1212 mass units). When xanosporolactone is compared to cercosporin (C29H26O10), the compositional difference between the two molecules is one carbon and four hydrogen atoms. The hydrogen magnetic resonance spectroscopy elemental formula of xanosporolactone (C28H22O10) indicates that there is a formal loss of CH4 from cercosporin (C29H26O10). However, nuclear magnetic resonance data indicate that there is a loss of one methoxyl group and therefore a gain of one oxygen atom (
CH3OH + O =
CH4), with the creation of one carboxylic acid equivalent. Since the nuclear magnetic resonance data for substituents on three of the rings of xanosporolactone are almost identical to the data for cercosporin, all of the reactions must occur in a single ring. A plausible biodegradation pathway would be initiated by cytochrome P-450 monooxygenase-mediated insertion of oxygen into one of the quinonoid rings of cercosporin, expanding the ring to a seven-member cyclic ester (lactone). Subsequent, and possibly spontaneous, hydrolytic opening of the lactone ring could be followed by spontaneous recyclization to a six-member oxygen-containing ring accompanied by loss of the methoxy group to form the previously unknown 4,9-dihydroxy-3-oxaperylene-10H-10-one chromophore of xanosporolactone. A detailed spectroscopic and structural analysis will be described in a separate publication (Mitchell et al., submitted for publication).
Bioassay of xanosporic acid and xanosporolactone toxicities.
The toxicities of xanosporic acid and xanosporolactone were tested by using a cercosporin-sensitive mutant of C. nicotianae and tobacco leaf tissue, respectively. The results of the fungal assay for xansoporic acid toxicity are shown in Table 2. When the cercosporin-sensitive mutant CS-8 was grown in cercosporin-containing medium preinoculated with nondegrading isolate XCP-76, cercosporin in the medium inhibited the growth of the fungus. When cercosporin was converted to xanosporic acid by preinoculation with the degrading isolate XCZ-3, CS-8 grew to levels equivalent to those in nontreated malt medium or in non-cercosporin-containing medium preinoculated with XCZ-3.
|
View this table: [in a new window] |
TABLE 2. Assay of toxicity of xanosporic acid to a cercosporin-sensitive mutant (CS-8) of C. nicotianaea
|
|
|
|---|
The long-term goal of our studies is to develop a strategy for the control of diseases caused by Cercospora species by transforming hosts with genes encoding proteins that can degrade cercosporin to nontoxic products. There are a number of precedents for this approach. For example, resistance to a trichothecene mycotoxin has been obtained by mobilizing into sensitive yeast a gene encoding an enzyme that acetylates the toxin (30). While yeasts are not natural hosts for fungi that produce trichothecenes, this study showed that genes involved in detoxification may be transferred to and protect toxin-sensitive organisms. A gene that codes for tabtoxin-specific degradation has provided resistance in transformed tobacco plants to the tabtoxin-producing bacterial pathogen Pseudomonas syringae pv. tabaci (2, 48). A gene (VR-ERE) isolated from Eutypa lata-tolerant grapevines, which encodes a protein that reduces the toxin eutypine to its corresponding alcohol, conferred resistance to eutypine in grapevine cells, although it has yet to be shown that whole-plant resistance can be achieved (11, 21).
We report identification of bacterial isolates that have the capacity to detoxify and degrade the fungal toxin cercosporin. Of 244 bacterial isolates screened, 40 were able to degrade 85% or more of the cercosporin in the growth medium. The best degrading isolates were X. campestris pv. zinniae isolate XCZ-3, X. campestris pv. pruni isolate XCP-77, and two unidentified propane users. Cercosporin-degrading bacteria previously identified by Robeson et al. (37) were originally isolated from plant tissue infected with Cercospora; thus, the tissue contained cercosporin. The degrading isolates which we found were isolated from plants with no known infestation of cercosporin-producing fungi. There is no intuitive reason why these bacteria have this capability. No naturally occurring perylenequinones have been identified yet from Xanthomonas species or their host plants (4). Furthermore, Cercospora species are not known to be significant members of the microflora of the leaf surfaces of these hosts. However, Xanthomonas species have been identified that are capable of degrading diverse organic compounds that they may not commonly encounter in nature (1, 23, 34, 35, 41, 45). Selected examples of aromatic molecules degraded by Xanthomonas spp. include protocatechuate, phenylalanine, lignins, toluene, fuel oil, and styrene (1, 20, 29, 40, 45).
It is interesting that of the 43 isolates able to degrade cercosporin, 32 were X. campestris pv. zinniae isolates. Every isolate tested belonging to this pathovar was able to degrade cercosporin, even though the 32 isolates were isolated at different times (1985 through 1990) and came from diverse locations, including Raleigh, N.C., Lansing, Mich., and Winchester, Va. It is curious that for the other bacteria tested, not all of the isolates belonging to the same pathovar are capable of degrading cercosporin. These data suggest that there is heterogeneity within the pathovars studied.
Time course studies showed that degradation of cercosporin in liquid medium by XCZ-3 is rapid. Degradation is initiated within the first 12 h of culture growth and is completed by 60 h, giving an estimated rate of degradation of 0.83 µM·h-1. During the process of degradation, the toxin is transiently converted into a green nontoxic compound, which we isolated, purified, and identified as xanosporic acid via its lactone derivative. Time course experiments also showed that as cercosporin is degraded, the concentration of xanosporic acid increases; however, there is a distinct lag between the time that cercosporin is lost from the medium and the time that xanosporic acid accumulates. At this time, we are not able to explain the temporal lag between cercosporin degradation and detectable xanosporic acid accumulation. However, experiments whose results are not presented here have suggested that rapid sequestration of cercosporin in the capsular polysaccharide rather than internal degradation by the bacteria is the cause of this lag. Cell extracts of cultures previously containing XCZ-3 were tested for the ability to degrade cercosporin. In no experiment, and under no conditions, did the level of cercosporin decrease in response to these extracts, suggesting that cercosporin is not degraded outside the cell (data not shown).
Elucidation of the structure of xanosporic acid may allow identification of the mechanism(s) involved in the early steps of cercosporin degradation. The enzymatic reaction may be as simple as a cytochrome P-450-mediated oxygen insertion. Insertion of an oxygen atom into one of the quinone rings of cercosporin is an example of the well-known Bayer-Villager chemical oxidation, which is also observed in several biological oxidations, including oxidation of aflatoxin B1 to aflatoxin G1. In this case, the responsible enzyme has properties of a cytochrome P-450 monooxygenase (microsomal localization and inhibition by P-450 inhibitors).
We thank Gary Payne, Pete Lindgren, and Marilyn Ehrenshaft for their suggestions and consultations.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»